The INNER-B post-market clinical follow-up study is undertaken to evaluate the prevention of death related to a thoracoabdominal aneurysm when treated by the E-nside TAAA Multibranch Stent Graft System.
The secondary objective is to evaluate the safety and clinical performance of the device.
Protocol Amendment History
5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-05-06; most recent amendment 2026-02-12.
Status change: Recruiting → Active, Not Recruiting2026-02-12
Status change: Not Yet Recruiting → Recruiting2020-12-07